Patent · US Active

Inhibitors of blood coagulation factor XIII

US11472838B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

Zedira GmbH · DE

Inventors

Martin Hils · Darmstadt, DE
Ralf Pasternack · Griesheim, DE
Christian Büchold · Karben, DE

Key dates

Filing date	Apr 17, 2019
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Apr 17, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of general formula (I) as novel inhibitor of blood coagulation factor XIII, methods for synthesis thereof and to use thereof for the prophylaxis or treatment of diseases associated with blood coagulation factor XIII.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.